All Stories

  1. Cervical cancer screening programme attendance and compliance predictors regarding Colombia’s Amazon region
  2. Preliminary Evaluation of the Safety and Immunogenicity of an Antimalarial Vaccine Candidate Modified Peptide (IMPIPS) Mixture in a Murine Model
  3. Using next‐generation sequencing for characterising HLA‐ DRB1 and DQB1 loci in a cohort of Colombian women
  4. Integrated genomic epidemiology and phenotypic profiling of Clostridium difficile across intra-hospital and community populations in Colombia
  5. Complement Receptor 1 availability on red blood cell surface modulates Plasmodium vivax invasion of human reticulocytes
  6. High frequency of toxigenic Clostridium difficile and Clostridium perfringens coinfection among diarrheic patients at health care facility-onset (HCFO) and community-onset (CO) centers in Bogotá, Colombia
  7. Sarconesin II, a New Antimicrobial Peptide Isolated from Sarconesiopsis magellanica Excretions and Secretions
  8. Specific Binding Peptides from Rv3632: A Strategy for Blocking Mycobacterium tuberculosis Entry to Target Cells?
  9. An epidemiological and molecular study regarding the spread of vancomycin-resistant Enterococcus faecium in a teaching hospital in Bogotá, Colombia 2016
  10. Behavior and abundance of Anopheles darlingi in communities living in the Colombian Amazon riverside
  11. Immunocompetent patient with a brain abscess caused by Nocardia beijingensis in Latin America
  12. Experimental models used in evaluating anti-tuberculosis vaccines: the latest advances in the field
  13. Parasite-Related Genetic and Epigenetic Aspects and Host Factors Influencing Plasmodium falciparum Invasion of Erythrocytes
  14. Comparative genomics identifies potential virulence factors in Clostridium tertium and C. paraputrificum
  15. Cryptosporidium spp. CP15 and CSL protein-derived synthetic peptides’ immunogenicity and in vitro seroneutralisation capability
  16. Plasmodium vivax Pv12 B-cell epitopes and HLA-DRβ1*-dependent T-cell epitopes in vitro antigenicity
  17. Association of HIV status with infection by multiple HPV types
  18. On the Evolution and Function of Plasmodium vivax Reticulocyte Binding Surface Antigen (pvrbsa)
  19. Correction to: Comparison of healing of full-thickness skin wounds grafted with multidirectional or unidirectional autologous artificial dermis: differential delivery of healing biomarkers
  20. Unveiling the Multilocus Sequence Typing (MLST) Schemes and Core Genome Phylogenies for Genotyping Chlamydia trachomatis
  21. Plasmodium vivax in vitro continuous culture: the spoke in the wheel
  22. Self-assembling functional programmable protein array for studying protein–protein interactions in malaria parasites
  23. Diagnostic accuracy of combinations of serological biomarkers for identifying clinical tuberculosis
  24. In silico and in vitro analysis of boAP3d1 protein interaction with bovine leukaemia virus gp51
  25. The in Vitro Antigenicity of Plasmodium vivax Rhoptry Neck Protein 2 (PvRON2) B- and T-Epitopes Selected by HLA-DRB1 Binding Profile
  26. Towards designing a synthetic antituberculosis vaccine: The Rv3587c peptide inhibits mycobacterial entry to host cells
  27. Comparison of healing of full-thickness skin wounds grafted with multidirectional or unidirectional autologous artificial dermis: differential delivery of healing biomarkers
  28. Specific β-Turns Precede PPIIL Structures Binding to Allele-Specific HLA-DRβ1* PBRs in Fully-Protective Malaria Vaccine Components
  29. Micro-epidemiology of mixed-species malaria infections in a rural population living in the Colombian Amazon region
  30. Simultaneous detection of Plasmodium vivax dhfr, dhps, mdr1 and crt-o resistance-associated mutations in the Colombian Amazonian region
  31. Receptor-ligand and parasite protein-protein interactions in Plasmodium vivax : Analysing rhoptry neck proteins 2 and 4
  32. Quantifying intracellular Mycobacterium tuberculosis : An essential issue for in vitro assays
  33. Mycobacterium tuberculosis H37Rv LpqG Protein Peptides Can Inhibit Mycobacterial Entry through Specific Interactions
  34. Easy and fast method for expression and native extraction of Plasmodium vivax Duffy binding protein fragments
  35. Identifying Potential Plasmodium vivax Sporozoite Stage Vaccine Candidates: An Analysis of Genetic Diversity and Natural Selection
  36. Evaluating the anti-leishmania activity of Lucilia sericata and Sarconesiopsis magellanica blowfly larval excretions/secretions in an in vitro model
  37. A novel loop-mediated isothermal amplification-based test for detecting Neospora caninum DNA
  38. Community-acquired infection with hypervirulent Clostridium difficile isolates that carry different toxin and antibiotic resistance loci: a case report
  39. Purification of Trypanosoma cruzi metacyclic trypomastigotes by ion exchange chromatography in sepharose-DEAE, a novel methodology for host-pathogen interaction studies
  40. Novel genes and mutations in patients affected by recurrent pregnancy loss
  41. Bovine leukaemia virus DNA in fresh milk and raw beef for human consumption
  42. Structural analysis of owl monkey MHC-DR shows that fully-protective malaria vaccine components can be readily used in humans
  43. Plasmodium vivax ligand-receptor interaction: PvAMA-1 domain I contains the minimal regions for specific interaction with CD71+ reticulocytes
  44. Critical role of HLA-DRβ* binding peptides' peripheral flanking residues in fully-protective malaria vaccine development
  45. PvGAMA reticulocyte binding activity: predicting conserved functional regions by natural selection analysis
  46. Characterising PvRBSA: an exclusive protein from Plasmodium species infecting reticulocytes
  47. New mutations in non-syndromic primary ovarian insufficiency patients identified via whole-exome sequencing
  48. Determining Clostridium difficile intra-taxa diversity by mining multilocus sequence typing databases
  49. Identifying and characterising PPE7 (Rv0354c) high activity binding peptides and their role in inhibiting cell invasion
  50. What Is Known about the Immune Response Induced by Plasmodium vivax Malaria Vaccine Candidates?
  51. Multiple high-risk HPV genotypes are grouped by type and are associated with viral load and risk factors
  52. pELMO, an optimised in-house cloning vector
  53. Transcriptome profiling of gene expression during immunisation trial against Fasciola hepatica: identification of genes and pathways involved in conferring immunoprotection in a murine model
  54. Multi-site protein-ligand quantum prediction
  55. The Aotus nancymaae erythrocyte proteome and its importance for biomedical research
  56. Far from the Madding Crowd: the Molecular Basis for Immunological Escape ofPlasmodium falciparum
  57. The effect of Lucilia sericata - and Sarconesiopsis magellanica -derived larval therapy on Leishmania panamensis
  58. Plasmodium malariae in the Colombian Amazon region: you don’t diagnose what you don’t suspect
  59. Evidence of functional divergence in MSP7 paralogous proteins: a molecular-evolutionary and phylogenetic analysis
  60. The Prevalence of High-Risk HPV Types and Factors Determining Infection in Female Colombian Adolescents
  61. Size polymorphism and low sequence diversity in the locus encoding the Plasmodium vivax rhoptry neck protein 4 (PvRON4) in Colombian isolates
  62. TCR-contacting residues orientation and HLA-DRβ* binding preference determine long-lasting protective immunity against malaria
  63. High Plasmodium malariae Prevalence in an Endemic Area of the Colombian Amazon Region
  64. Evaluating the Biological Cycle and Reproductive and Population Parameters ofCalliphora vicina(Diptera: Calliphoridae) Reared on Three Different Diets
  65. Mycobacterium tuberculosis PE9 protein has high activity binding peptides which inhibit target cell invasion
  66. Evaluating Sarconesiopsis magellanica blowfly-derived larval therapy and comparing it to Lucilia sericata-derived therapy in an animal model
  67. Chlamydia trachomatis Frequency in a Cohort of HPV-Infected Colombian Women
  68. Immune protection-inducing protein structures (IMPIPS) against malaria: the weapons needed for beating Odysseus
  69. Evidence of recent interspecies horizontal gene transfer regarding nucleopolyhedrovirus infection of Spodoptera frugiperda
  70. Characterising atypical Candida albicans clinical isolates from six third-level hospitals in Bogotá, Colombia
  71. Cell-Peptide Specific Interaction Can InhibitMycobacterium tuberculosis H37RvInfection
  72. Recent advances in the development of a chemically synthesised anti-malarial vaccine
  73. Inferring natural selection signals in Plasmodium vivax -encoded proteins having a potential role in merozoite invasion
  74. IMPIPS: The Immune Protection-Inducing Protein Structure Concept in the Search for Steric-Electron and Topochemical Principles for Complete Fully-Protective Chemically Synthesised Vaccine Development
  75. The DNA load of six high-risk human papillomavirus types and its association with cervical lesions
  76. New echinocandin susceptibility patterns for nosocomial Candida albicans in Bogotá, Colombia, in ten tertiary care centres: an observational study
  77. The effects of Sarconesiopsis magellanica larvae (Diptera: Calliphoridae) excretions and secretions on fibroblasts
  78. Terapia larval en la curación de heridas
  79. Combination of Mycobacterium tuberculosis immunodominant peptides and serum host response biomarkers for the diagnosis of tuberculosis
  80. Determining the Plasmodium vivax VCG-1 strain blood stage proteome
  81. Evaluating the Effect ofSarconesiopsis magellanica(Diptera: Calliphoridae) Larvae-Derived Haemolymph and Fat Body Extracts on Chronic Wounds in Diabetic Rabbits
  82. The Plasmodium vivax rhoptry neck protein 5 is expressed in the apical pole of Plasmodium vivax VCG-1 strain schizonts and binds to human reticulocytes
  83. Mce4F Mycobacterium tuberculosis protein peptides can inhibit invasion of human cell lines
  84. In Vitro and In Vivo Studies for Assessing the Immune Response and Protection-Inducing Ability Conferred by Fasciola hepatica-Derived Synthetic Peptides Containing B- and T-Cell Epitopes
  85. Sarconesiopsis magellanica (Diptera: Calliphoridae) excretions and secretions have potent antibacterial activity
  86. Persistence, clearance and reinfection regarding six high risk human papillomavirus types in Colombian women: a follow-up study
  87. Specific Interaction betweenMycobacterium tuberculosisLipoprotein-derived Peptides and Target Cells Inhibits Mycobacterial EntryIn Vitro
  88. Human papillomavirus detection in women with and without human immunodeficiency virus infection in Colombia
  89. Characterising a Microsatellite for DRB Typing in Aotus vociferans and Aotus nancymaae (Platyrrhini)
  90. Th1 and Th2 immune response to P30 and ROP18 peptides in human toxoplasmosis
  91. Gauche+ side-chain orientation as a key factor in the search for an immunogenic peptide mixture leading to a complete fully protective vaccine
  92. Plasmodium falciparum rhoptry neck protein 5 peptides bind to human red blood cells and inhibit parasite invasion
  93. Using the PfEMP1 Head Structure Binding Motif to Deal a Blow at Severe Malaria
  94. Heterogeneous genetic diversity pattern in Plasmodium vivax genes encoding merozoite surface proteins (MSP) -7E, −7F and -7L
  95. Low genetic diversity and functional constraint in loci encoding Plasmodium vivax P12 and P38 proteins in the Colombian population
  96. Low genetic diversity in the locus encoding the Plasmodium vivax P41 protein in Colombia’s parasite population
  97. Proteolytic activity regarding Sarconesiopsis magellanica (Diptera: Calliphoridae) larval excretions and secretions
  98. Sarconesiopsis magellanica (Diptera: Calliphoridae) life-cycle, reproductive and population parameters using different diets under laboratory conditions
  99. Identification and Diversity of Killer Cell Ig-Like Receptors in Aotus vociferans, a New World Monkey
  100. Rv1268c protein peptide inhibiting Mycobacterium tuberculosis H37Rv entry to target cells
  101. Classical Molecular Tests Using Urine Samples as a Potential Screening Tool for Human Papillomavirus Detection in Human Immunodeficiency Virus-Infected Women
  102. Reticulocytes:Plasmodium vivaxtarget cells
  103. Rh1 high activity binding peptides inhibit high percentages of Plasmodium falciparum FVO strain invasion
  104. Immunologic evaluation and validation of methods using synthetic peptides derived from Mycobacterium tuberculosis for the diagnosis of tuberculosis infection
  105. Enterococcus faecalis internalization in human umbilical vein endothelial cells (HUVEC)
  106. Mammaglobin peptide as a novel biomarker for breast cancer detection
  107. Functional, biochemical and 3D studies ofMycobacterium tuberculosisprotein peptides for an effective anti-tuberculosis vaccine
  108. Human Papillomavirus Detection from Human Immunodeficiency Virus-Infected Colombian Women's Paired Urine and Cervical Samples
  109. Annotation and characterization of the Plasmodium vivax rhoptry neck protein 4 (PvRON4)
  110. Characterizing PvARP, a novel Plasmodium vivax antigen
  111. The GPI-anchored 6-Cys Protein Pv12 is Present in Detergent-resistant Microdomains of Plasmodium vivax Blood Stage Schizonts
  112. Mycobacterium tuberculosis surface protein Rv0227c contains high activity binding peptides which inhibit cell invasion
  113. Vaccines againstPlasmodium vivax: a research challenge
  114. The diagnostic performance of classical molecular tests used for detecting human papillomavirus
  115. Genetic Diversity and Selection in Three Plasmodium vivax Merozoite Surface Protein 7 (Pvmsp-7) Genes in a Colombian Population
  116. The role of Mycobacterium tuberculosis Rv3166c protein-derived high-activity binding peptides in inhibiting invasion of human cell lines
  117. A single amino acid change in the Plasmodium falciparum RH5 (PfRH5) human RBC binding sequence modifies its structure and determines species-specific binding activity
  118. 3D structure and immunogenicity of Plasmodium falciparum sporozoite induced associated protein peptides as components of fully-protective anti-malarial vaccine
  119. Detection by PCR of human papillomavirus in Colombia: Comparison of GP5+/6+ and MY09/11 primer sets
  120. Bacterial Translocation in Abdominal Trauma and Postoperative Infections
  121. Identification of Plasmodium vivax Proteins with Potential Role in Invasion Using Sequence Redundancy Reduction and Profile Hidden Markov Models
  122. Binding activity, structure, and immunogenicity of synthetic peptides derived from Plasmodium falciparum CelTOS and TRSP proteins
  123. Synthetic peptides from two Pf sporozoite invasion-associated proteins specifically interact with HeLa and HepG2 cells
  124. Identifying and characterizing a member of the RhopH1/Clag family in Plasmodium vivax
  125. Peptides derived from Mycobacterium tuberculosis Rv2301 protein are involved in invasion to human epithelial cells and macrophages
  126. Structural and Immunological Principles Leading to Chemically Synthesized, Multiantigenic, Multistage, Minimal Subunit-Based Vaccine Development
  127. Frequency of Human Papillomavirus Infection, Coinfection, and Association with Different Risk Factors in Colombia
  128. Identification of the Plasmodium falciparum rhoptry neck protein 5 (PfRON5)
  129. Low genetic polymorphism of merozoite surface proteins 7 and 10 in Colombian Plasmodium vivax isolates
  130. Distribution Patterns of Infection with Multiple Types of Human Papillomaviruses and Their Association with Risk Factors
  131. The Mycobacterium tuberculosis membrane protein Rv0180c: Evaluation of peptide sequences implicated in mycobacterial invasion of two human cell lines
  132. Plasmodium vivax lineages: geographical distribution, tandem repeat polymorphism, and phylogenetic relationship
  133. Characterisation and comparative analysis of MHC-DPA1 exon 2 in the owl monkey (Aotus nancymaae)
  134. Identification, characterization and antigenicity of the Plasmodium vivax rhoptry neck protein 1 (PvRON1)
  135. Molecular modeling and in silico characterization of Mycobacterium tuberculosis TlyA: Possible misannotation of this tubercle bacilli-hemolysin
  136. NClassG+: A classifier for non-classically secreted Gram-positive bacterial proteins
  137. PvRON2, a new Plasmodium vivax rhoptry neck antigen
  138. Conserved regions of the Plasmodium falciparum rhoptry-associated protein 3 mediate specific host-pathogen interactions during invasion of red blood cells
  139. Evaluation of the antigenicity of universal epitopes from PvDBPII in individuals exposed to Plasmodium vivax malaria
  140. Conserved high activity binding peptides from the Plasmodium falciparum Pf34 rhoptry protein inhibit merozoites in vitro invasion of red blood cells
  141. Mechanisms of genetically-based resistance to malaria
  142. Computational Prediction and Experimental Assessment of Secreted/Surface Proteins from Mycobacterium tuberculosis H37Rv
  143. Conserved High Activity Binding Peptides are Involved in Adhesion of Two Detergent-Resistant Membrane-Associated Merozoite Proteins to Red Blood Cells during Invasion
  144. Differential expansion of the merozoite surface protein (msp)-7 gene family in Plasmodium species under a birth-and-death model of evolution
  145. Conserved regions from Plasmodium falciparum MSP11 specifically interact with host cells and have a potential role during merozoite invasion of red blood cells
  146. HLA class II polymorphism in Latin American patients with multiple sclerosis
  147. 3D Analysis of the TCR/pMHCII Complex Formation in Monkeys Vaccinated with the First Peptide Inducing Sterilizing Immunity against Human Malaria
  148. Sequences of the Plasmodium falciparum cytoadherence-linked asexual protein 9 implicated in malaria parasite invasion to erythrocytes
  149. Limited genetic polymorphism of the Plasmodium vivax low molecular weight rhoptry protein complex in the Colombian population
  150. Well-Defined Regions of thePlasmodium falciparumReticulocyte Binding Protein Homologue 4 Mediate Interaction with Red Blood Cell Membrane
  151. Peptides from the Mycobacterium tuberculosis Rv1980c protein involved in human cell infection: insights into new synthetic subunit vaccine candidates
  152. Mycobacterium tuberculosis Rv0679c protein sequences involved in host-cell infection: Potential TB vaccine candidate antigen
  153. Atomic fidelity of subunit-based chemically-synthesized antimalarial vaccine components
  154. Identification and characterization of the Plasmodium vivax thrombospondin-related apical merozoite protein
  155. Vaccination with recombinant Plasmodium vivax MSP-10 formulated in different adjuvants induces strong immunogenicity but no protection
  156. Characterization and antigenicity of the promising vaccine candidate Plasmodium vivax 34kDa rhoptry antigen (Pv34)
  157. Synthetic peptides from conserved regions of the Plasmodium falciparum early transcribed membrane and ring exported proteins bind specifically to red blood cell proteins
  158. Toxoplasma gondii: P30 peptides recognition pattern in human toxoplasmosis
  159. Fine mapping of Plasmodium falciparum ribosomal phosphoprotein PfP0 revealed sequences with highly specific binding activity to human red blood cells
  160. Immunogenicity and protection-inducing ability of recombinant Plasmodium vivax rhoptry-associated protein 2 in Aotus monkeys: A potential vaccine candidate
  161. Prevalence of HPV-DNA and Anti-HPV Antibodies in Women From Girardot, Colombia
  162. Validating subcellular localization prediction tools with mycobacterial proteins
  163. Prevalence of infection with high-risk human papillomavirus in women in Colombia
  164. Identification and evaluation of universal epitopes in Plasmodium vivax Duffy binding protein
  165. The Plasmodium vivax Pv41 surface protein: Identification and characterization
  166. Characterisation of the Plasmodium vivax Pv38 antigen
  167. Strategies for developing multi-epitope, subunit-based, chemically synthesized anti-malarial vaccines
  168. Specificity of L1 Peptides versus Virus-Like Particles for Detection of Human Papillomavirus-Positive Cervical Lesions in Females Attending Engativa Hospital, Bogota, Colombia
  169. Characterization ofPlasmodium falciparumintegral membrane protein Pf25-IMP and identification of its red blood cell binding sequences inhibiting merozoite invasion in vitro
  170. Peptides derived from the Mycobacterium tuberculosis Rv1490 surface protein implicated in inhibition of epithelial cell entry: Potential vaccine candidates?
  171. Functional characterization of Mycobacterium tuberculosis Rv2969c membrane protein
  172. Shifting the Polarity of some Critical Residues in Malarial Peptides Binding to Host Cells is a Key Factor in Breaking Conserved Antigens Code of Silence
  173. Emerging Rules for Subunit-Based, Multiantigenic, Multistage Chemically Synthesized Vaccines
  174. Characterizing theMycobacterium tuberculosisRv2707 protein and determining its sequences which specifically bind to two human cell lines
  175. Quantitative flow cytometric monitoring of invasion of epithelial cells by Mycobacterium tuberculosis
  176. The Mycobacterium tuberculosis membrane protein Rv2560 − biochemical and functional studies
  177. A Novel Methodology for Characterizing and Predicting Protein Functional Sites
  178. Characterizing and Predicting Catalytic Residues in Enzyme Active Sites Based on Local Properties: A Machine Learning Approach
  179. Synthetic genes: a tool for identifying human papillomavirus genotypes by hybridization and polymerase chain reaction-based assays
  180. A pre-PEXEL histidine-rich protein II erythrocyte binding peptide as a new way for anti-malarial vaccine development
  181. Identifying and characterising the Plasmodium falciparum RhopH3 Plasmodium vivax homologue
  182. The antigenicity of a Plasmodium vivax reticulocyte binding protein-1 (PvRBP1) recombinant fragment in humans and its immunogenicity and protection studies in Aotus monkeys
  183. Synthetic vaccine update: Applying lessons learned from recent SPf66 malarial vaccine physicochemical, structural and immunological characterization
  184. Functional, structural, and immunological compartmentalisation of malaria invasive proteins
  185. Characterisation of Plasmodium falciparum RESA-like protein peptides that bind specifically to erythrocytes and inhibit invasion
  186. Cloning, expression, and characterisation of a Plasmodium vivax MSP7 family merozoite surface protein
  187. High polymorphism in Plasmodium vivax merozoite surface protein-5 (MSP5)
  188. The Plasmodium vivax rhoptry-associated protein 1
  189. Plasmodium falciparum TryThrA antigen synthetic peptides block in vitro merozoite invasion to erythrocytes
  190. Identification of five different IGHV gene families in owl monkeys (Aotus nancymaae)
  191. Identifying putativeMycobacterium tuberculosisRv2004c protein sequences that bind specifically to U937 macrophages and A549 epithelial cells
  192. A B-lymphocyte binding peptide from BNRF1 induced antibodies inhibiting EBV-invasion of B-lymphocytes
  193. Identification and characterisation of the Plasmodium vivax rhoptry-associated protein 2
  194. High level of conservation in Plasmodium vivax merozoite surface protein 4 (PvMSP4)☆
  195. Mycobacterium tuberculosisRv2536 protein implicated in specific binding to human cell lines
  196. Gamma interferon levels and antibody production induced by two PvMSP-1 recombinant polypeptides are associated with protective immunity against P. vivax in Aotus monkeys
  197. Characterising Mycobacterium tuberculosis Rv1510c protein and determining its sequences that specifically bind to two target cell lines
  198. Identifying and characterising the Plasmodium falciparum merozoite surface protein 10 Plasmodium vivax homologue
  199. Amino terminal peptides from the Plasmodium falciparum EBA-181/JESEBL protein bind specifically to erythrocytes and inhibit in vitro merozoite invasion
  200. Cutaneous tuberculosis diagnosis in an inhospitable Amazonian region by means of telemedicine and molecular biology
  201. The T-cell receptor in primates: identifying and sequencing new owl monkey TRBV gene sub-groups
  202. Identifying Plasmodium falciparum cytoadherence-linked asexual protein 3 (CLAG 3) sequences that specifically bind to C32 cells and erythrocytes
  203. MHC class I genes in the owl monkey: mosaic organisation, convergence and loci diversity
  204. Plasmodium vivax merozoite surface protein 8 cloning, expression, and characterisation
  205. Quantifying Aotus monkey cytokines by real-time quantitative RT-PCR
  206. Liver stage antigen 3 Plasmodium falciparum peptides specifically interacting with HepG2 cells
  207. Identifying gp85-regions involved in Epstein–Barr virus binding to B-lymphocytes
  208. Plasmodium vivax Duffy binding protein: a modular evolutionary proposal
  209. Isolation and identification of mycobacteria in New World primates maintained in captivity
  210. Characterizing T-cell receptor gamma-variable gene in Aotus nancymaae owl monkey peripheral blood
  211. Splenectomised and spleen intact Aotus monkeys? immune response to Plasmodium vivax MSP-1 protein fragments and their high activity binding peptides
  212. A highly infective Plasmodium vivax strain adapted to Aotus monkeys: Quantitative haematological and molecular determinations useful for P. vivax malaria vaccine development
  213. alpha1 and alpha2 domains of Aotus MHC Class I and Catarrhini MHC Class Ia share similar characteristics
  214. Expression, polymorphism analysis, reticulocyte binding and serological reactivity of two Plasmodium vivax MSP-1 protein recombinant fragments
  215. Identification and polymorphism of Plasmodium vivax RBP-1 peptides which bind specifically to reticulocytes
  216. Plasmodium vivax: parasitemia determination by real-time quantitative PCR in Aotus monkeys
  217. Plasmodium vivax: functional analysis of a highly conserved PvRBP-1 protein region
  218. Plasmodium vivax: Polymorphism in the Merozoite Surface Protein 1 Gene from Wild Colombian Isolates
  219. Genetic restriction in two conserved regions of Plasmodium falciparum EBA-175t
  220. Genetic polymorphism of the Duffy receptor binding domain of Plasmodium vivax in Colombian wild isolates